A research article focused on Jamaican medicinal plants and authored by Dr Henry Lowe and his Biotech R&D team, has earned a spot in the respected peer-reviewed journal, the European Journal of Medicinal Plants, Jamaica’s Observer reports.
The Journal is dedicated to publishing high quality papers in all areas of medicinal plants research, including plant growth and development, agronomic management, plant nutrition, plant physiology, cell biology, molecular biology, biotechnology, medicinal properties, and more.
Dr Lowe and his team recently discovered that proprietary extracts, from Guinea Hen Weed and Dibenzyl Trisulfide (a major chemical constituent), from the Jamaican variety of Guinea Hen Weed, have significantly inhibited the survival of the HIV virus.
“Even though these findings are still at the early stages of development, they show extremely promising potential, which could also impact the treatment of other viral diseases,’ Dr Lowe stated.
“This is especially important at this time, since several Caribbean Islands and other parts of the world, in particular countries in Africa, which are plagued by the HIV pandemic, but also life-threatening diseases, such as the re-emergence of viruses that cause Chikungunya and Ebola.”, he noted.
HIV is the cause of the Acquired Human Immunodeficiency Syndrome (AIDS), which has claimed million of lives, and continue to do so, despite the discovery and development of Highly Active Antiretroviral Therapies (HAART).
The full scientific publication is contained in the online version of the European Journal of Medicinal Plants Volume 5(1) under the title: Petiveria alliacea L (Guinea Hen Weed) and its major metabolite dibenzyl trisulfide demonstrate HIV-1 reverse transcriptase inhibitory activity.
For the original report go to http://www.jamaicaobserver.com/latestnews/Anti-HIV-activity-claimed-for-Jamaican-Guinea-Hen-Weed